- For 2026, Medpace guides to 8.9%-12.8% revenue growth versus 2025 results.
- 2026 GAAP EPS guidance is $16.68 to $17.50, as disclosed with first-quarter results.
- President Jesse Geiger will retire effective May 31, 2026, according to the SEC filing.
Thursday, April 23, 2026
Medpace Q1 2026 non-GAAP EPS $4.28 (+17% YoY) and revenue $706.6M (+27% YoY)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.